Efficacy and safety of ponatinib (PON) in patients with chronic-phase chronic myeloid leukemia (CP-CML) who failed one or more second-generation (2G) tyrosine kinase inhibitors (TKIs): Analyses based on PACE and OPTIC Meeting Abstract
| Authors: | Kantarjian, H. M.; Deininger, M. W.; Abruzzese, E.; Apperley, J.; Cortes, J. E.; Chuah, C.; DeAngelo, D. J.; DiPersio, J. F.; Hochhaus, A.; Lipton, J. H.; Nicolini, F. E.; Ibarz, J. P.; Rea, D.; Rosti, G.; Rousselot, P.; Shah, N. P.; Talpaz, M.; Srivastava, S.; Lu, V.; Mauro, M. J. |
| Abstract Title: | Efficacy and safety of ponatinib (PON) in patients with chronic-phase chronic myeloid leukemia (CP-CML) who failed one or more second-generation (2G) tyrosine kinase inhibitors (TKIs): Analyses based on PACE and OPTIC |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607547200132 |
| DOI: | 10.1182/blood-2020-133922 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 43 -- Source: Wos |
